It acts on hematopoietic progenitor cells, promotes their proliferation and differentiation, stimulates the maturation of granulocytes, mononuclear macrophages, promotes the release of mature cells into peripheral blood, and can promote the various functions of macrophages and eosinophils.

This product is a long-acting interferon formed by combining recombinant human interferon α2b with polyethylene glycol (40kDY type). It has the functions of inhibiting viral replication in infected cells, inhibiting cell proliferation, and having immunomodulatory effects.

This product is a long-acting interferon formed by combining recombinant human interferon α2b with polyethylene glycol (40kDY type), which has the effects of inhibiting viral replication in infected cells, inhibiting cell proliferation and immunomodulation. Its pharmacodynamic characteristics are similar to those of natural or recombinant human α-interferon, but the pharmacokinetics are very different.

This product is a long-acting interferon formed by the combination of recombinant human interferon α2b and polyethylene glycol (40kDY type). It can bind to specific α-interferon receptors on the cell surface, trigger complex signal transduction pathways in cells and activate gene transcription, regulate multiple biological effects, including inhibiting viral replication in infected cells, inhibiting cell proliferation, and has an immunomodulatory effect.

This product is human granulocyte colony-stimulating factor (rhGCSF) produced by genetic recombination technology. It is one of the main cytokines regulating granulocyte hematopoiesis in the bone marrow. It selectively acts on granulocyte hematopoietic progenitor cells, promotes their proliferation and differentiation, and can increase the function of terminally differentiated granulocyte cells.